StockTalk: How are ASX medtechs responding to skyrocketing healthcare spending?

StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Dr Nigel Finch discusses skyrocketing healthcare spending and its impact on the medtech sub-sector.

Populating the expert panel this week is Jason Waller, CEO & MD of Intelicare (ASX:ICR), Geoff Pocock, executive director of Osteopore (ASX:OSX) and Marjan Mikel, CEO & MD of Respiri (ASX:RSH).

The group discusses a range of topics, including how the medtech sector has reacted to increased funding, if the trend will continue post COVID-19, which firms are capitalising, which regions are primed for medtech adoption, the question of affordability and more.

So tune in above to hear the panel discuss these questions.

 

The post StockTalk: How are ASX medtechs responding to skyrocketing healthcare spending? appeared first on Stockhead.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *